3 ms·
Given how medicine works in the US, that's not a problem, but an opportunity. US Medicine is for profit, and the money is in reoccuring treatment, not cures. S
by balls187 8y ago
Given how medicine works in the US, that's not a problem, but an opportunity.
US Medicine is for profit, and the money is in reoccuring treatment, not cures. So a never ending battle of cat-and-mouse is the type of R&D phramas would love.
A potential future scenario:
Keep going to your doctor to get a Rx for the latest strain or pay a monthly fee to a Bacteriophage-As-A-Service SV tech company to get the latest delivered right to your door you use in conjunction with a smartphone app.
The latter of which would have operated illegally until sufficiently large enough to hire insider DC lobbyists to gut the FDA.
- DonaldFisk 8y agoAnd yet phage therapy's been successfully used under communism but not capitalism. This is because it's cheap, low tech, and there are no economic barriers to market entry.
- AstralStorm 8y agoYou forgot to mention the scale. It does not easily scale as the required laboratory space to handle even a few hundred phage strains is enormous. Please provide numbers of patients treated with phages, time to treat one and efficacy numbers.